These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1929097)

  • 1. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary].
    Gadducci A; Ferdeghini M; Prato B; Bartolini T; Nicolini A; Scatena P; Facchini V; Bianchi R; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1985; 106(1):34-9. PubMed ID: 2994537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 7. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 9. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
    Lahousen M
    Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
    Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
    Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
    Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
    Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A
    G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
    Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R; Kaesemann H; Caffier H
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor markers CEA, TPA and CA 19-9 in gastric cancer.
    Putzki H; Reichert B; Jablonski M; Heymann H
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(3-4):145-8. PubMed ID: 3234297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of five tumor marker assay in patients with lung cancer.
    Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
    Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.